Drug Testing Locations - New Britain, CT

Drug Testing in New Britain, CT

New Britain, Connecticut Statistics

In 2021, New Britain, located in Hartford County, recorded approximately 50 opioid-related overdose deaths.

The New Britain, Hartford County emergency services reported over 200 drug-related emergency calls in 2022.

Substance abuse treatment admissions in Hartford County saw a 15% increase from 2021 to 2022.

A 2022 study found that 10% of high school students in New Britain reported using illegal substances.

The city of New Britain, Hartford County, observed a 25% rise in drug-related arrests in 2022.

A local nonprofit in New Britain, Hartford County, served 1,000 individuals seeking recovery assistance in 2022.

How does the body eliminate Drugs

Drug elimination is the sum of the processes of removing an administered drug from the body. In the pharmacokinetic ADME scheme (absorption, distribution, metabolism, and excretion), it is frequently considered to encompass both metabolism and excretion. Hydrophobic drugs, to be excreted, must undergo metabolic modification making them more polar. Hydrophilic drugs, on the other hand, can undergo excretion directly, without the need for metabolic changes to their molecular structures.

Although many sites of metabolism and excretion exist, the chief organ of metabolism is the liver, while the organ primarily tasked with excretion is the kidney. Any significant dysfunction in either organ can result in the accumulation of the drug or its metabolites in toxic concentrations.

A variety of other factors impact elimination — intrinsic drug properties, such as polarity, size, or pKa. Also other factors include genetic variation among individuals, disease states affecting other organs, and pathways involved in the way the drug distributes through the body, such as first-pass metabolism.

Issues of Concern

Drug elimination is the removal of an administered drug from the body. It is accomplished in two ways, either by excretion of an unmetabolized drug in its intact form or by metabolic biotransformation followed by excretion. While excretion is primarily carried out by the kidneys, other organ systems are involved as well. Similarly, the liver is the primary site of biotransformation, yet extrahepatic metabolism takes place in a variety of organ systems affecting multiple drugs.

Given the multiple organ systems and the variety of metabolic transformations present, drug elimination can entail a significant degree of complexity. Hydrophilic drugs are typically directly excreted by the kidneys, while hydrophobic drugs undergo biotransformation before excretion. The purpose here is twofold – biotransformation serves both detoxify the exogenous substances as well as to increase their hydrophilicity, ensuring their elimination via the kidneys.

Two broad metabolic pathways of hepatic drug transformation exist. Phase I is the direct modification of the target molecule, whereas phase II entails conjugation of the target to a polar molecule of low molecular weight. Phase I prepare the drug to enter phase II, but single-phase metabolism also exists.

Phase I involves oxidation, reduction, and hydrolysis of the exogenous molecule. These reactions are accomplished by hepatic microsomal enzymes, which reside in the smooth endoplasmic reticulum of the hepatocytes. Best known among them is the cytochrome P450 system, whose enzymes are predominantly involved in oxidative metabolism. Within the cytochrome P450 family (CYP), the enzyme responsible for the metabolism of more than 50% of existing drugs is the CYP3A4. Its activity encompasses various classes of medications, including opioids, immunosuppressants, antihistamines, and benzodiazepines. The enzymes can also be induced or inhibited by a variety of substances they interact with, including pharmaceuticals. The increase in metabolic activity with CYP induction results in a diminished activity of drugs targeted by that particular isoform. Conversely, CYP inhibition will result in increased drug plasma concentration, potentially leading toxicity. The CYP3A4 is induced by phenytoin, phenobarbital, and St. John's wort, while diltiazem, erythromycin, and grapefruit inhibit it. Caution is, therefore, necessary when administering CYP3A4-metabolized drugs in the presence of any of the inhibitors or inducers.

Phase II consists of covalent bonding of polar groups to nonpolar molecules to render them water-soluble and allow renal or biliary excretion. Target molecules enter phase II directly or via initial processing through phase I. A variety of polar adjuncts is transferred, including amino acids, glucuronic acid, glutathione, acetate, and sulfate. Glucuronidation is one of the major pathways of phase II biotransformation. The UDP-glucuronosyltransferase (UGT) enzyme family performs this activity. Typically, glucuronide derivatives possess less or no activity of the original drug, but in some cases, pharmacologically active compounds result. Morphine-6-glucuronide is a phase II metabolite of morphine with significant analgesic activity. As with the CYP enzymes, inducers, and inhibitors of phase II, enzymes exist and may influence the efficacy of drugs that rely on conjugation before excretion.

The first-pass effect is a feature of hepatic metabolism that also plays a role in the elimination of multiple drugs. Here, the enteric consumed drugs are exposed directly to the liver via the portal vein, where they undergo biotransformation before entering the systemic circulation. This activity reduces the bioavailability and needs to be factored into the dose administered to the patient. Intravenously administered drugs are not subject to the first-pass effect.

Extrahepatic drug metabolism takes place in the GI tract, kidneys, lungs, plasma, and skin.

Renal excretion completes the process of elimination that begins in the liver. Polar drugs or their metabolites get filtered in the kidneys and typically do not undergo reabsorption. They subsequently get excreted in the urine. Urinary pH has a significant impact on excretion, as drug ionization changes depending on the alkaline or acidic environment. Increased excretion occurs with weakly acidic drugs in basic urine and weakly basic drugs in acidic urine.

Excretion in the bile is another significant form of drug elimination. The liver can actively secrete ionized drugs with a molecular weight greater than 300 g/mol into bile, from where they reach the digestive tract and are either eliminated in feces or reabsorbed as part of the enterohepatic cycle.

Other pathways of excretion include the lungs, breast milk, sweat, saliva, and tears

Employers in New Britain, CT & Drug Testing Policies

Employers in New Britain, CT, are increasingly adopting stringent drug testing policies to maintain a safe and productive workplace. The Connecticut Department of Labor provides resources on implementing such policies, available here.

Many large companies in Hartford County are also using drug testing as part of their hiring process, ensuring compliance with state labor laws. They are required to adhere to guidelines set by the U.S. Department of Labor.

Government Efforts with Drug Problems in New Britain, CT

The government of New Britain, CT, along with Hartford County, has initiated various programs to counteract drug abuse. The city's collaboration with the Connecticut Department of Mental Health and Addiction Services aims to provide comprehensive treatment options.

Furthermore, local law enforcement in partnership with the Substance Abuse and Mental Health Services Administration (SAMHSA) conducts regular community outreach and educational programs to raise awareness of drug dangers and prevention methods.

Local Drug Busts & News in New Britain, CT

In recent months, the New Britain Police Department has intensified its efforts to curtail drug-related activities, resulting in a series of successful drug busts. Working alongside state and federal agencies, these operations have led to significant arrests and seizures of illegal substances, disrupting supply chains and making local neighborhoods safer.

One notable event involved the arrest of several individuals linked to a regional drug trafficking ring. The coordinated operation uncovered large quantities of heroin and fentanyl, substances believed to be connected to a surge in overdose cases. This operation highlights the collaborative efforts of law enforcement in addressing the crisis.

The community has been urged to remain vigilant and report any suspicious activity as authorities focus on education and prevention strategies. New Britain officials are also partnering with local organizations to provide resources for addiction recovery, aiming to reduce demand and support those affected by substance abuse.

Occupational Health Services

Accredited Drug Testing offers fast, reliable employment screening services in New Britain, CT. Trusted by employers nationwide for accurate results and exceptional service.

Connecticut DOT/Non DOT Physicals

Connecticut Vision Tests

Connecticut Audiograms

Connecticut Respirator Fit Tests

Connecticut Lift Tests

Connecticut Background Checks

Clinical Testing Services

TB Testing in CT

Diabetes Testing in CT

Infectious Disease Testing in CT

Sickle Cell Anemia Testing in CT

Women/Men's Health Testing in CT

Resources & Citations

Courant Connecticut Drug Abuse

Connecticut Children's

CT Addiction Services

Crash Cars Hartford

Hartford Dispenser

Drug Rehab Connecticut

Connecticut DMHAS Services

CITA Connecticut

Drug Testing Near New Britain, CT

Newtown, CT

Plantsville, CT

Wethersfield, CT

Rocky Hill, CT

West Hartford, CT

Southington, CT

Cromwell, CT

Farmington, CT

Plainville, CT

Newington, CT

Berlin, CT

Kensington, CT

Franklin, CT

Frequently Asked Questions

Customer Reviews